Kewaunee Scientific (NASDAQ:KEQU – Get Free Report) was upgraded by investment analysts at StockNews.com from a “hold” rating to a “buy” rating in a note issued to investors on Monday.
Kewaunee Scientific Trading Down 2.8 %
KEQU opened at $41.31 on Monday. The stock has a market cap of $118.56 million, a PE ratio of 6.63 and a beta of 0.80. The business has a 50 day moving average of $35.74 and a 200-day moving average of $41.98. Kewaunee Scientific has a 52 week low of $17.01 and a 52 week high of $55.62. The company has a quick ratio of 2.00, a current ratio of 2.53 and a debt-to-equity ratio of 0.48.
Kewaunee Scientific (NASDAQ:KEQU – Get Free Report) last released its earnings results on Wednesday, September 11th. The technology company reported $0.93 earnings per share for the quarter. Kewaunee Scientific had a net margin of 9.13% and a return on equity of 25.87%. The firm had revenue of $48.39 million for the quarter.
Institutional Inflows and Outflows
About Kewaunee Scientific
Kewaunee Scientific Corporation designs, manufactures, and installs laboratory, healthcare, and technical furniture and infrastructure products. The company operates through two segments, Domestic and International. Its products include steel and wood casework, fume hoods, adaptable modular systems, moveable workstations, stand-alone benches, biological safety cabinets, and epoxy resin work surfaces and sinks.
See Also
- Five stocks we like better than Kewaunee Scientific
- Dividend King Proctor & Gamble Is A Buy On Post-Earnings Weakness
- Beyond NVIDIA: Top 5 Semiconductor Stocks to Watch for 2025
- 5 discounted opportunities for dividend growth investors
- Netflix Is On Track To Hit $1,000 By Christmas
- Why Are These Companies Considered Blue Chips?
- UMAC Stock Climbs Amid Trump Jr. Appointment and Meme Stock Hype
Receive News & Ratings for Kewaunee Scientific Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Kewaunee Scientific and related companies with MarketBeat.com's FREE daily email newsletter.